Glutamate as a Marker of Cognitive Function in Schizophrenia: A Proton Spectroscopic Imaging Study at 4 Tesla
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background Cognitive deficits in schizophrenia may be related to glutamatergic dysfunction, but in-vivo measurement of glutamate metabolism has been challenging. We examined the relationship between glutamate metabolism and cognitive function in schizophrenia. Methods Thirty subjects with DSM-IV schizophrenia and 28 healthy volunteers, were studied using 4 Tesla proton echo planar spectroscopic imaging. Glutamate plus glutamine (Glx), N-acetyl-aspartate compounds (NAAc) and Inositol (Ins) concentrations in gray and white matter and broad neuropsychological function were assessed in all subjects. Results Glx was positively correlated with overall cognitive performance in the schizophrenia group (p=0.0006), accounting for about 36% of the variance. No correlation was found in controls. Group-averaged Glx levels were similar in schizophrenia and controls. NAAc was reduced in cortical gray matter in the younger schizophrenia subjects (age <30; p=0.04) compared to age-matched controls. Ins was increased in cortical gray (p=0.002) and white matter (p=0.02) in the older schizophrenia subjects (age>30) compared to age-matched controls. Conclusions Although not reduced in schizophrenia as a group, lower Glx levels correlates with impaired cognition in the illness. This suggests heterogeneity in mechanisms that regulate glutamate function in schizophrenia. Patients with reduced glutamatergic reserves may be rendered into a more severe hypoglutamatergic state with cognitive consequences. Reduced cortical gray matter NAAc concentration early in the illness with normalization in older subjects, is consistent with a process of early dendritic retraction with subsequent increased neuronal packing. Later in the illness, Ins elevation suggests glial involvement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033430 · Cited by 2,999
A review of MRI findings in schizophrenia
Shenton, M. E., Dickey, C. C., Frumin, M., & McCarley, R. W. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00163-3 · Cited by 2,346 · cited 2×
“This location has broad coverage of gray/white matter in bilateral frontal and parietal regions, where metabolic (16), structural (11) and functional abnormalities (17) have been reported in schizophrenia.”
BackgroundGlutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685 · cited 1×
“It has been postulated that a glutamate-related process accounts for cognitive impairment in schizophrenia (2).”
BackgroundThe neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677
Decreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia
Glantz, L. A., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.65 · Cited by 1,636
Buchanan, R. W., Javitt, D. C., Marder, S. R., Schooler, N. R., Gold, J. M., McMahon, R. P., Heresco-Levy, U., & Carpenter, W. T. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06081358 · Cited by 419 · cited 1×
“Some glutamate-related strategies have been tried with limited success (43).”
BackgroundSteen, R. G., Hamer, R. M., & Lieberman, J. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300850 · Cited by 254 · cited 1×
“This location has broad coverage of gray/white matter in bilateral frontal and parietal regions, where metabolic (16), structural (11) and functional abnormalities (17) have been reported in schizophrenia.”
Background1H-MRS at 4 Tesla in minimally treated early schizophrenia
Bustillo, J. R., Rowland, L. M., Mullins, P., Jung, R., Chen, H., Qualls, C., Hammond, R., Brooks, W. M., & Lauriello, J. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.121 · Cited by 153 · cited 2×
“We separated Gln from Glu in medial GM regions, and found increased Gln/Glu, a measure perhaps closer to synaptic glutamate in the YouSz group, as previously reported (51).”
Result
Cited by
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
Wang, M., Yang, Y., Wang, C.-J., Gamo, N. J., Jin, L. E., Mazer, J. A., Morrison, J. H., Wang, X.-J., & Arnsten, A. F. T. (2013) · Neuron · doi:10.1016/j.neuron.2012.12.032 · Cited by 489
“Recent findings indicate that impaired cognitive abilities in patients with schizophrenia are associated with reduced NMDAR glutamate signaling (Bustillo et al., 2011), rather than the hyperglutamate signaling that has been the focus of recent theories (reviewed in Kantrowitz and Javitt, 2012).”
BackgroundGlutamate in Schizophrenia: A Focused Review and Meta-Analysis of 1H-MRS Studies
Marsman, A., van den Heuvel, M. P., Klomp, D. W. J., Kahn, R. S., Luijten, P. R., & Hulshoff Pol, H. E. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr069 · Cited by 457
Merritt, K., Egerton, A., Kempton, M. J., Taylor, M. J., & McGuire, P. K. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0442 · Cited by 367
The neurobiology and treatment of first-episode schizophrenia
Kahn, R. S., & Sommer, I. E. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.66 · Cited by 219
Metadata
- Authors
- Bustillo, J. R., Chen, H., Gasparovic, C., Mullins, P., Caprihan, A., Qualls, C., Apfeldorf, W., Lauriello, J., & Posse, S.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 69
- Issue
- 1
- Pages
- 19-27
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W2087789431
- Cited by
- 96
- References
- 8
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glutamate as a Marker of Cognitive Function in Schizophrenia: A Proton Spectroscopic Imaging Study at 4 Tesla. https://app.cochat.ai/papers/10.1016/j.biopsych.2010.08.024
- The paper
- Bustillo, J. R., Chen, H., Gasparovic, C., Mullins, P., Caprihan, A., Qualls, C., Apfeldorf, W., Lauriello, J., & Posse, S. (2011). Glutamate as a Marker of Cognitive Function in Schizophrenia: A Proton Spectroscopic Imaging Study at 4 Tesla. Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2010.08.024
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.